Your browser doesn't support javascript.
loading
The Historical Evolution of Ocular Tuberculosis: Past, Present, and Future.
Betzler, Bjorn Kaijun; Gunasekeran, Dinesh Visva; Kempen, John; Smith, Justine R; McCluskey, Peter; Nguyen, Quan Dong; Pavesio, Carlos; Gupta, Vishali; Agrawal, Rupesh.
Afiliación
  • Betzler BK; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Gunasekeran DV; Singapore Eye Research Institute, Singapore, Singapore.
  • Kempen J; National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore.
  • Smith JR; Moorfields Eye Hospital and Biomedical Research Centre, Institute of Ophthalmology, University College London, London, UK.
  • McCluskey P; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.
  • Nguyen QD; Department of Ophthalmology, Massachusetts Eye and Ear Infirmary and Harvard Medical School, Boston, Massachusetts, USA.
  • Pavesio C; MyungSung Christian Medical Center (MCM) Eye Unit, MCM General Hospital and MyungSung Medical School, Addis Ababa, Ethiopia.
  • Gupta V; Flinders University College of Medicine and Public Health, Adelaide, Australia.
  • Agrawal R; Save Sight Institute, Sydney Eye Hospital, Sydney, Australia.
Ocul Immunol Inflamm ; 30(3): 593-599, 2022 Apr 03.
Article en En | MEDLINE | ID: mdl-34752203
ABSTRACT
Ocular involvement is a rare manifestation of tuberculosis. Four key issues historically faced by clinicians when diagnosing and treating ocular tuberculosis - diagnostic uncertainty, naturally heterogeneous presentations, limitations of existing laboratory diagnostic tools, and non-uniform treatment guidelines - continue to test today's physicians. Unparalleled scientific and clinical developments over the past century have greatly expanded the knowledge surrounding this challenging ophthalmic condition. Experience with large volumes of cases at tuberculosis-endemic centres has led to recent growth in knowledge and physician experience, perhaps more so in developing countries. Looking forward, the role of diverse new technologies, including artificial intelligence and proteomics, will advance ocular tuberculosis research. Efforts have been made to address the lack of standardized nomenclature, diagnostic uncertainty, and unvalidated, geographically variable treatment guidelines.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Tuberculosis Ocular Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Ocul Immunol Inflamm Asunto de la revista: ALERGIA E IMUNOLOGIA / OFTALMOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Singapur

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tuberculosis / Tuberculosis Ocular Tipo de estudio: Diagnostic_studies / Guideline Límite: Humans Idioma: En Revista: Ocul Immunol Inflamm Asunto de la revista: ALERGIA E IMUNOLOGIA / OFTALMOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Singapur